BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19133574)

  • 1. Valproate-induced hyperammonemic encephalopathy.
    Chou HF; Yang RC; Chen CY; Jong YJ
    Pediatr Neonatol; 2008 Oct; 49(5):201-4. PubMed ID: 19133574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproate-induced hyperammonemic encephalopathy treated by hemodialysis.
    Tsai MF; Chen CY
    Ren Fail; 2008; 30(8):822-4. PubMed ID: 18791959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproate-induced hyperammonemic encephalopathy, rapidly improved by i.v. carnitine and glucose/thiamine.
    Bøhmer T; Bøen A; Høymork SC
    Scand J Gastroenterol; 2010 Jun; 45(6):762-3. PubMed ID: 20163200
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyperammonaemic encephalopathy after initiation of valproate therapy in unrecognised ornithine transcarbamylase deficiency.
    Oechsner M; Steen C; Stürenburg HJ; Kohlschütter A
    J Neurol Neurosurg Psychiatry; 1998 May; 64(5):680-2. PubMed ID: 9598692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproic acid-induced hyperammonemic encephalopathy with triphasic waves.
    Kifune A; Kubota F; Shibata N; Akata T; Kikuchi S
    Epilepsia; 2000 Jul; 41(7):909-12. PubMed ID: 10897167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hyperammonemic encephalopathy associated with valproate acid].
    Osuna MT; Burcet J; Ramió L; Ustrell X; Silva Y; Molins A
    Neurologia; 2003; 18(6):347-50. PubMed ID: 12838456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproate induced hyperammonemic encephalopathy successfully treated with levocarnitine.
    Rigamonti A; Lauria G; Grimod G; Bianchi G; Salmaggi A
    J Clin Neurosci; 2014 Apr; 21(4):690-1. PubMed ID: 24119342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two cases of valproate-induced hyperammonemic encephalopathy without hepatic failure.
    Panda S; Radhakrishnan K
    J Assoc Physicians India; 2004 Sep; 52():746-8. PubMed ID: 15839456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproate-associated hyperammonemic encephalopathy.
    Wadzinski J; Franks R; Roane D; Bayard M
    J Am Board Fam Med; 2007; 20(5):499-502. PubMed ID: 17823470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproate-induced hyperammonemic encephalopathy.
    Segura-Bruna N; Rodriguez-Campello A; Puente V; Roquer J
    Acta Neurol Scand; 2006 Jul; 114(1):1-7. PubMed ID: 16774619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Valproic acid-induced hyperammonemic encephalopathy in a patient receiving valproic acid monotherapy].
    Yamada H; Shishido T; Mukai T; Araki M; Naka H; Tokinobu H
    Rinsho Shinkeigaku; 2019 May; 59(5):258-263. PubMed ID: 31061301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproate-induced hyperammonemic encephalopathy.
    Murphy JV
    Epilepsia; 2003 Feb; 44(2):268; author reply 268. PubMed ID: 12558587
    [No Abstract]   [Full Text] [Related]  

  • 13. Valproate-induced hyperammonemic encephalopathy in a renal transplanted patient.
    Melexopoulou C; Marinaki S; Darema M; Skalioti C; Efthimiou A; Zavos G; Boletis JN
    Ren Fail; 2014 Jul; 36(6):955-6. PubMed ID: 24665854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different clinical manifestations of hyperammonemic encephalopathy.
    Gomceli YB; Kutlu G; Cavdar L; Sanivar F; Inan LE
    Epilepsy Behav; 2007 Jun; 10(4):583-7. PubMed ID: 17412645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Valproate-induced hyperammonemic encephalopathy].
    Granel B; Gavaret M; Le Baut X; Sautereau N; Rodriguez D; Rossi P; Bagnères D; Demoux AL; Francès Y
    Rev Med Interne; 2011 Jun; 32(6):e72-5. PubMed ID: 20633966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metabolic encephalopathy can be a potentially life-threatening complication from valproic acid].
    Meinardi MC; van den Berg GB; Groenhuijzen A; Driessen JT; Maas HA; Wolfhagen FH
    Ned Tijdschr Geneeskd; 2008 Feb; 152(5):278-82. PubMed ID: 18333544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperammonemic encephalopathy induced by a combination of valproate and pivmecillinam.
    Lokrantz CM; Eriksson B; Rosén I; Asztely F
    Acta Neurol Scand; 2004 Apr; 109(4):297-301. PubMed ID: 15016014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Valproate-associated hyperammonemic encephalopathy. Report of one case].
    Young P; Finn BC; Alvarez F; Bruetman JE; Trimarchi H
    Rev Med Chil; 2007 Nov; 135(11):1446-9. PubMed ID: 18259656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproate-induced hyperammonemic encephalopathy in the presence of topiramate.
    Solomon GE
    Neurology; 2000 Aug; 55(4):606. PubMed ID: 10953214
    [No Abstract]   [Full Text] [Related]  

  • 20. Valproate-induced hyperammonemic encephalopathy.
    Bhatia H; Raman PG
    J Assoc Physicians India; 2005 Feb; 53():158. PubMed ID: 15847043
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.